Literature DB >> 10195829

A comparative evaluation of substance abuse treatment: I. Treatment orientation, amount of care, and 1-year outcomes.

R H Moos1, J W Finney, P C Ouimette, R T Suchinsky.   

Abstract

This article first explains the conceptual framework and plan of a naturalistic, multisite evaluation of Department of Veterans Affairs (VA) substance abuse treatment programs. It then examines the effectiveness of an index episode of inpatient treatment and the effectiveness of continuing outpatient care and participation in self-help groups. The study was conducted among 3018 patients from 15 VA programs that emphasized 12-Step, cognitive-behavioral (CB), or eclectic treatment. Casemix-adjusted 1-year outcomes showed that patients in 12-Step programs were the most likely to be abstinent, free of substance abuse problems, and employed at the 1-year follow-up. Patients who obtained more regular and more intensive outpatient mental health care, and those who participated more in 12-Step self-help groups, were more likely to be abstinent and free of substance use problems at the 1-year follow-up. These findings support the effectiveness of 12-Step treatment and show that patients with substance use disorders who become more involved in outpatient care and self-help groups tend to experience better short-term substance use outcomes. Subsequent papers in this section focus on the proximal outcomes of treatment, patients with psychiatric as well as substance use disorders, patient-treatment matching effects, and the link between program treatment orientation and patients' involvement in and the influence of 12-Step self-help groups.

Entities:  

Mesh:

Year:  1999        PMID: 10195829

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  31 in total

1.  Support, mutual aid and recovery from dual diagnosis.

Authors:  A B Laudet; S Magura; H S Vogel; E Knight
Journal:  Community Ment Health J       Date:  2000-10

2.  Mediators of effectiveness in dual-focus self-help groups.

Authors:  Stephen Magura; Edward L Knight; Howard S Vogel; Daneyal Mahmood; Alexandre B Laudet; Andrew Rosenblum
Journal:  Am J Drug Alcohol Abuse       Date:  2003-05       Impact factor: 3.829

3.  Predictors of retention in dual-focus self-help groups.

Authors:  Alexandre B Laudet; Stephen Magura; Charles M Cleland; Howard S Vogel; Edward L Knight
Journal:  Community Ment Health J       Date:  2003-08

4.  Perceived reasons for substance misuse among persons with a psychiatric disorder.

Authors:  Alexandra B Laudet; Stephen Magura; Howard S Vogel; Edward L Knight
Journal:  Am J Orthopsychiatry       Date:  2004-07

5.  Social support mediates the effects of dual-focus mutual aid groups on abstinence from substance use.

Authors:  Alexandre B Laudet; Charles M Cleland; Stephen Magura; Howard S Vogel; Edward L Knight
Journal:  Am J Community Psychol       Date:  2004-12

6.  The Role of Social Supports, Spirituality, Religiousness, Life Meaning and Affiliation with 12-Step Fellowships in Quality of Life Satisfaction Among Individuals in Recovery from Alcohol and Drug Problems.

Authors:  Alexandre B Laudet; Keith Morgen; William L White
Journal:  Alcohol Treat Q       Date:  2006

7.  Substance Abuse Treatment Providers' Referral to Self-Help: Review and Future Empirical Directions.

Authors:  Alexandre B Laudet
Journal:  Int J Self Help Self Care       Date:  2000

Review 8.  The impact of alcoholics anonymous on other substance abuse-related twelve-step programs.

Authors:  Alexandre B Laudet
Journal:  Recent Dev Alcohol       Date:  2008

9.  12-step facilitation for the dually diagnosed: a randomized clinical trial.

Authors:  Michael P Bogenschutz; Samara L Rice; J Scott Tonigan; Howard S Vogel; Joseph Nowinski; Donald Hume; Pamela B Arenella
Journal:  J Subst Abuse Treat       Date:  2013-12-21

Review 10.  Treatment of the depressed alcoholic patient.

Authors:  Jeffrey J DeVido; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.